GT Biopharma (GTBP) Share-based Compensation (2010 - 2026)
GT Biopharma (GTBP) posted Share-based Compensation of $46,000 for Q2 2026, compared with $4,000 a year earlier and unchanged from the prior quarter.
GT Biopharma (GTBP) Share-based Compensation (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at GT Biopharma was $517,000; for FY2025, it was $432,000, up 87.8% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 9.9% (FY2020 to FY2025).
- In prior years, GT Biopharma's Share-based Compensation was $230,000 in FY2024 (-87.0%), $1.77 million in FY2023 (-41.6%), $3.03 million in FY2022 and $251,000 in FY2021 (-6.7%).
- Quarterly Share-based Compensation has run from a low of -$10.21 million in Q4 2021 to a high of $2.59 million in Q3 2022 over five years.
- On a year-over-year basis, Share-based Compensation increased in 1 of the last four quarters, with growth averaging 45.8%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2022, with growth of 700.0%; the weakest was Q4 2024, with a decline of 98.2%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $46,000 (Q1 2026), $46,000 (Q4 2025) and $379,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 362.00 Mn |
| 10 | GT Biopharma | 6.65 Mn | -16.58 Mn | - | 46,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46,000.00 |
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | 46,000.00 |
| Sep 30, 2025 | 379,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 102,000.00 |
| Dec 31, 2023 | 433,000.00 |
| Sep 30, 2023 | 432,000.00 |
| Jun 30, 2023 | 729,000.00 |
| Mar 31, 2023 | 176,000.00 |
| Dec 31, 2022 | -822,000.00 |
| Sep 30, 2022 | 2.59 Mn |
| Jun 30, 2022 | 390,000.00 |
| Mar 31, 2022 | 872,000.00 |
| Dec 31, 2021 | -10.21 Mn |
| Sep 30, 2021 | 324,000.00 |
| Jun 30, 2021 | 327,000.00 |
GT Biopharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GTBP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();